What is the Y-tunnus number of Inflames Pharma Oy?

Inflames Pharma Oy is registered with PRH / YTJ under Y-tunnus 1790854-1.

What is the revenue of Inflames Pharma Oy?

Inflames Pharma Oy reported revenue of 1,2 t. € in 2025.

Markku Tapani Jalkanen is the CEO of Inflames Pharma Oy, in role since 2003.

Juho Markku Jalkanen chairs the board of Inflames Pharma Oy, in role since 2022.

Inflames Pharma Oy's registered address is Brahenkatu 20.

OYActive

Actively employed in the business

Name	Role	Member since
Current (1)
MT Markku Tapani Jalkanen Chief Executive Officer	Chief Executive Officer	2003

Former (2)


JT Jari Tapio Henttula Deputy auditor	Deputy auditor	2002 – 2022
KE Kauko Esko Ilmari Lehtonen Audit	Audit	2002 – 2022

Non-executive oversight

Name	Role	Member since
Current (3)
MT Markku Tapani Jalkanen Board of Directors	Board of Directors	2003
MK Maija-Leena Kaarina Hollmén Board of Directors	Board of Directors	2022
JM Juho Markku Jalkanen Chairperson	Chairperson	2022

Former (4)


ME Matti Esa Manner Chairperson	Chairperson	2003 – 2022
MH Marko Henrikki Salmi Board of Directors	Board of Directors	2003 – 2022
JV Juha Veikko Peltola

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.